388 related articles for article (PubMed ID: 24002160)
21. Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation.
Desai S; Ayres E; Bak H; Manco M; Lynch S; Raab S; Du A; Green D; Skobowiat C; Wangari-Talbot J; Zheng Q
J Drugs Dermatol; 2019 May; 18(5):454-459. PubMed ID: 31141852
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the Safety and Efficacy of a Topical Formulation Containing Epidermal Growth Factor, Tranexamic Acid, Vitamin C, Arbutin, Niacinamide and Other Ingredients as Hydroquinone 4% Alternatives to Improve Hyperpigmentation: A Prospective, Randomized, Controlled Split Face Study.
Kalasho BD; Minokadeh A; Zhang-Nunes S; Zoumalan RA; Shemirani NL; Waldman AR; Pletzer V; Zoumalan CI
J Cosmet Sci; 2020; 71(5):263-290. PubMed ID: 33022197
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
[TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
[TBL] [Abstract][Full Text] [Related]
25. Topical agents used in the management of hyperpigmentation.
Halder RM; Richards GM
Skin Therapy Lett; 2004; 9(6):1-3. PubMed ID: 15334278
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
Bruce S
J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
[TBL] [Abstract][Full Text] [Related]
27. The role of systemic treatments for skin lightening.
Juhasz MLW; Levin MK
J Cosmet Dermatol; 2018 Dec; 17(6):1144-1157. PubMed ID: 30133125
[TBL] [Abstract][Full Text] [Related]
28. The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentation.
Leyden J; Wallo W
Int J Dermatol; 2011 Apr; 50(4):470-7. PubMed ID: 21332714
[TBL] [Abstract][Full Text] [Related]
29. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.
Davis EC; Callender VD
J Clin Aesthet Dermatol; 2010 Jul; 3(7):20-31. PubMed ID: 20725554
[TBL] [Abstract][Full Text] [Related]
30. Hyperpigmentation and melasma.
Rigopoulos D; Gregoriou S; Katsambas A
J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
[TBL] [Abstract][Full Text] [Related]
32. Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review.
Hollinger JC; Angra K; Halder RM
J Clin Aesthet Dermatol; 2018 Feb; 11(2):28-37. PubMed ID: 29552273
[No Abstract] [Full Text] [Related]
33. Treatment of hyperpigmentation.
Woolery-Lloyd H; Kammer JN
Semin Cutan Med Surg; 2011 Sep; 30(3):171-5. PubMed ID: 21925372
[TBL] [Abstract][Full Text] [Related]
34. Natural options for management of melasma, a review.
Nomakhosi M; Heidi A
J Cosmet Laser Ther; 2018; 20(7-8):470-481. PubMed ID: 29461133
[TBL] [Abstract][Full Text] [Related]
35. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation.
Cook-Bolden FE; Hamilton SF
Cutis; 2008 Apr; 81(4):365-71. PubMed ID: 18491487
[TBL] [Abstract][Full Text] [Related]
36. New and experimental treatments of cloasma and other hypermelanoses.
Picardo M; Carrera M
Dermatol Clin; 2007 Jul; 25(3):353-62, ix. PubMed ID: 17662901
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Insights in Melasma and Hyperpigmentation Management.
Huerth KA; Hassan S; Callender VD
J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
[TBL] [Abstract][Full Text] [Related]
38. Laser treatment of pigmented lesions for Asians.
Wong JK
Facial Plast Surg Clin North Am; 2011 May; 19(2):417-22. PubMed ID: 21764000
[TBL] [Abstract][Full Text] [Related]
39. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P; Callender V
Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging.
Fabi S; Massaki N; Goldman MP
J Drugs Dermatol; 2012 Aug; 11(8):964-8. PubMed ID: 22859242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
